Decision Trail

Stage 1: Scope Fit

Feb 7, 2026, 07:49 PM
GoRisk: 0%
RuleInputResultExplanation
modality
IN_LIST biologics, gene_therapy, gene therapy, cell_therapy, cell therapy, adc, antibody drug conjugate
small moleculePASSmodality passed check
scale
IN_LIST commercial_dp, commercial drug product, commercial scale
500gPASSscale passed check
modality
CONTAINS hpapi category 4
small moleculePASSmodality passed check
timeline
CONTAINS urgent, asap, rush, immediate
not providedNEEDS_INFOtimeline not provided in inquiry
devStage
IN_LIST phase 1, phase 2, phase 3, clinical, preclinical
not providedNEEDS_INFOdevStage not provided in inquiry
modality
IN_LIST small molecule, peptide, oligonucleotide
small moleculeGOModality within standard CDMO capabilities
Questions still needed:
  • What is the timeline? (needed for: Aggressive timeline may not be achievable with standard scheduling)
  • What is the devStage? (needed for: Clinical-stage work is core CDMO capability)
Already answered by narrative:
  • modality already answered: "small molecule" (confidence: 0.60)
  • scale already answered: "500g" (confidence: 0.90)
  • modality already answered: "small molecule" (confidence: 0.60)
  • modality already answered: "small molecule" (confidence: 0.60)

Stage 2: Feasibility

Feb 7, 2026, 07:49 PM
ConditionalRisk: 23%
RuleInputResultExplanation
Technical Complexity
SCORE > 0.5
0.90GOStandard chemistry, within capability
Scale Feasibility
SCORE > 0.5
0.90GOScale within standard capacity
GMP Implications
SCORE > 0.5
0.50GOGMP requirement unclear, needs clarification
Analytical Burden
SCORE > 0.5
0.80GOAnalytical requirements manageable
Timeline Realism
SCORE > 0.5
0.60GONo timeline specified
Safety Risks
SCORE > 0.5
0.90GONo significant safety concerns identified
Conditions:
  • GMP requirement not confirmed
Questions still needed:
  • Is GMP manufacturing required, or is this for research/development only?
SME review required

Manual Overrides (1)

CONDITIONALGOSTAGE_2 by ADMIN on Feb 7, 2026, 07:51 PM

Justification: This is a custom synthesis/ R&D project with scale up. Assign it to SME directly